Systematic review / meta-analysis / 2018
Omega-3 intake showed little to no effect on cardiovascular mortality or events
A systematic review of 79 randomized trials including 112,059 adults assessed long-chain omega-3 and alpha-linolenic acid interventions. Increasing long-chain omega-3 had little or no effect on all-cause mortality (RR 0.98, 95% CI 0.90 to 1.03) or cardiovascular events (RR 0.99, 95% CI 0.94 to 1.04). Plant-based alpha-linolenic acid slightly reduced cardiovascular events (RR 0.95, 95% CI 0.83 to 1.07) and coronary mortality (RR 0.95, 95% CI 0.72 to 1.26) based on low-quality evidence.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 79 randomized controlled trials, 112,059 adult participants
- What was measured
- All-cause mortality and cardiovascular events
THE PAPER
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, AlAbdulghafoor FK, Summerbell CD, Worthington HV, Song F, Hooper L. Cochrane Database Syst Rev, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.